The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schneider Eugene since 2021.
This trader's CIK number is 1838539.
At the time of last reporting, Schneider Eugene was the EVP, Chf Clinical Develop Ofcr of Ionis Pharmaceuticals Inc. (stock ticker symbol IONS).
Also see all insider trading activities at Ionis Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IONS | 0 | $0 | 37,214 | $1,868,304 | 37,030 | $1,057,010 |
| 2024 | IONS | 0 | $0 | 15,553 | $807,085 | 23,162 | $260,800 |
| 2023 | IONS | 0 | $0 | 31,165 | $1,532,088 | 38,046 | $1,183,500 |
| 2022 | IONS | 0 | $0 | 0 | $0 | 10,816 | $0 |
| 2021 | IONS | 0 | $0 | 0 | $0 | 7,920 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | IONS | Sale | 19,658 | 60.94 | 1,197,938 |
| 2025-09-03 | IONS | Option Ex | 19,658 | 53.77 | 1,057,010 |
| 2025-08-04 | IONS | Sale | 9,549 | 42.80 | 408,697 |
| 2025-01-31 | IONS | Sale | 1,484 | 32.20 | 47,780 |
| 2025-01-16 | IONS | Sale | 6,523 | 32.79 | 213,889 |
| 2025-01-15 | IONS | Option Ex | 17,372 | .00 | 0 |
| 2024-02-02 | IONS | Sale | 2,071 | 49.59 | 102,700 |
| 2024-01-17 | IONS | Sale | 5,482 | 50.42 | 276,385 |
| 2024-01-16 | IONS | Option Ex | 15,162 | .00 | 0 |
| 2024-01-12 | IONS | Option Ex | 8,000 | 32.60 | 260,800 |
| 2024-01-12 | IONS | Sale | 8,000 | 53.50 | 428,000 |
| 2023-12-26 | IONS | Sale | 25,000 | 51.46 | 1,286,575 |
| 2023-12-26 | IONS | Option Ex | 25,000 | 47.34 | 1,183,500 |
| 2023-02-06 | IONS | Sale | 1,413 | 40.67 | 57,463 |
| 2023-01-18 | IONS | Sale | 4,752 | 39.57 | 188,050 |
| 2023-01-17 | IONS | Option Ex | 13,046 | .00 | 0 |
| 2022-10-17 | IONS | Option Ex | 416 | .00 | 0 |
| 2022-01-18 | IONS | Option Ex | 10,400 | .00 | 0 |
| 2021-10-15 | IONS | Option Ex | 417 | .00 | 0 |
| 2021-01-15 | IONS | Option Ex | 7,503 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schneider Eugene (EVP, Chf Clinical Develop Ofcr of Ionis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.